Chapter 2: Van der Waals forces and Hydrophobic Interactions in Ligand-protein Interactions#
1. Introduction#
Van der Waals forces are weak, short-range attractive interactions that occur when atoms from a drug molecule and its target protein come into close proximity (typically 3-4 Å). While individually weak (0.5-1 kcal/mol per contact), these forces are numerous across a binding interface—a typical drug-protein complex may have 50-100 van der Waals contacts contributing 25-50% of total binding energy. Understanding these forces is essential because they reward shape complementarity: drugs that fit snugly into binding pockets maximize favorable contacts while minimizing steric clashes.
2. Key Concepts and Definitions#
Van der Waals forces: Weak, short-range attractive forces between atoms arising from transient charge fluctuations (London dispersion) and permanent dipole interactions, effective at 3-4 Å distances.
London dispersion forces: Instantaneous dipole-induced dipole attractions that occur between all atoms; stronger for larger, more polarizable atoms like sulfur, chlorine, and aromatic carbons.
Hydrophobic effect The entropy-driven burial of nonpolar surfaces that works synergistically with van der Waals forces to favor compact binding geometries.
3. Main Content#
3.1 Types of van der Waals Interactions in Drug Binding#
London dispersion forces dominate drug-protein interactions, occurring between all atom pairs regardless of polarity. These arise from correlated electron fluctuations creating transient dipoles. Larger atoms (Cl, Br, S, aromatic carbons) are more polarizable and form stronger dispersion interactions—explaining why many drugs incorporate halogens or aromatic rings.
Dipole-dipole interactions occur between permanent dipoles in polar groups. The C=O···C=O interaction between amide groups (~1 kcal/mol) is common at protein-ligand interfaces. These are directional and require proper geometric alignment, making them valuable for binding specificity.
Dipole-induced dipole forces arise when polar groups polarize nearby nonpolar atoms. A carbonyl oxygen can induce a dipole in an adjacent aromatic ring, creating an additional attractive force that stabilizes specific binding orientations.
Non-Covalent Interactions Summary#
Interaction Type |
Typical Strength |
Distance Range |
Key Properties |
|---|---|---|---|
London dispersion |
0.5 - 1.0 kcal/mol |
3.5 - 4.0 Å |
All atoms; stronger for larger atoms |
Dipole-dipole |
0.5 - 2.0 kcal/mol |
3.0 - 4.0 Å |
Directional; requires alignment |
π-π stacking |
2 - 4 kcal/mol |
3.5 - 4.0 Å |
Face-to-face or T-shaped geometries |
CH-π interaction |
1 - 2 kcal/mol |
3.0 - 4.0 Å |
Alkyl/aromatic CH to π system |
London Dispersion Forces
Permanent Dipole - Induced Dipole (Debye Force)
3.2 Contribution of Van der Waals Forces to Binding Affinity and Selectivity#
Van der Waals forces contribute 20-50% of total binding free energy for typical drugs, with the remainder from hydrogen bonds, salt bridges, and entropy changes. Their cumulative strength derives from having many contacts.
Quantitative contribution: Individual van der Waals contacts contribute approximately:
0.5-1.0 kcal/mol per contact for typical C···C, C···N, C···O interactions
1.0-1.5 kcal/mol per contact for interactions involving polarizable atoms (Cl, Br, S)
2-4 kcal/mol for optimized π-π stacking between aromatic rings
A drug making 60-100 van der Waals contacts contributes 30-75 kcal/mol before entropy penalties
Temperature sensitivity Van der Waals forces show weak temperature dependence compared to hydrogen bonds, making them reliable interaction components across physiological temperature ranges.
3.3 The Hydrophobic Effect in Drug Binding#
The hydrophobic effect is the most misunderstood force in drug discovery—it’s not about “water-hating” molecules attracting each other, but rather an entropy-driven phenomenon where water molecules gain freedom when nonpolar surfaces are buried.
Water molecules surrounding a nonpolar surface (like a hydrophobic drug fragment) form ordered “cages” with restricted movement to maintain hydrogen bonding. When the drug binds and these surfaces are buried in a protein pocket, the ordered water molecules are released into bulk solvent, dramatically increasing system entropy. This entropy gain (TΔS) is the hydrophobic effect’s driving force.
3.4 Contribution of the Hydrophobic Effect to Binding Affinity and Selectivity#
Quantitative contribution: The hydrophobic effect contributes approximately:
-0.02 to -0.04 kcal/mol per Ų of buried nonpolar surface area
For a typical drug burying 400 Ų of hydrophobic surface: 8-16 kcal/mol favorable
This often exceeds contributions from hydrogen bonds (2-5 kcal/mol each)
Temperature dependence: Unlike van der Waals forces, the hydrophobic effect strengthens with temperature because entropy (TΔS) increases. This explains why some protein-ligand complexes show unusual temperature-binding profiles.
In summary, here is a table that summarizes the difference between Van der Waals forces and the hydrophobic effect
Property |
Van der Waals |
Hydrophobic Effect |
|---|---|---|
Physical origin |
Electron fluctuations |
Water entropy gain |
Thermodynamics |
Enthalpic (ΔH) |
Entropic (TΔS) |
Distance dependence |
Strong (r⁻⁶) |
Indirect (via surface burial) |
Surface type |
All atoms |
Nonpolar surfaces only |
Temperature effect |
Weak |
Strong (increases with T) |
Contribution |
~0.5-1 kcal/mol per contact |
~0.02-0.04 kcal/mol per Ų |
Van der Waals forces and the hydrophobic effect work together. When a drug’s hydrophobic group (phenyl ring) binds a protein’s hydrophobic pocket (Phe, Leu, Val residues):
Van der Waals forces provide specific attractive interactions
Hydrophobic effect provides global driving force for surface burial
4. Practical Applications#
Fragment-Based Drug Discovery (FBDD): Scientists screen libraries of small, low-affinity “fragments” to find ones that bind to a target’s hydrophobic pockets. Once a fragment “hit” is identified, chemists use knowledge of VdW forces and the hydrophobic effect to “grow” the fragment into a larger, more potent lead molecule by adding chemical groups that progressively fill the binding site and maximize shape complementarity.
Improving Oral Bioavailability: The hydrophobicity of a drug, often measured by LogP, is a critical factor in its ability to be absorbed after being taken orally. A drug must be hydrophobic enough to pass through cell membranes but soluble enough to dissolve in the gut. Computational chemists use cLogP calculations to fine-tune a drug’s structure to achieve the optimal hydrophobic/hydrophilic balance for good bioavailability.
Designing Specificity into Kinase Inhibitors: Many protein kinases share structurally similar ATP binding sites. To design an inhibitor that only targets one specific kinase, developers exploit subtle differences in the shape and character of adjacent hydrophobic pockets. By tailoring a drug’s nonpolar side chains to perfectly match the VdW surface of the target kinase—and clash with the surface of off-target kinases—they can achieve remarkable specificity and reduce side effects.
5. Summary and Key Takeaways#
In this section, we’ve explored how the hydrophobic effect and Van der Waals forces work in concert to drive drug-protein binding. We learned that the hydrophobic effect provides the initial “push” into the binding site, driven by a favorable increase in the entropy of water, while VdW forces create the final, stabilizing “fit” through maximized shape complementarity.
Van der Waals forces are weak individually (0.5-1 kcal/mol) but collectively powerful through numerous contacts across binding interfaces. Combined with the hydrophobic effect, these nonpolar interactions contribute 40-70% of total binding energy for typical drug-protein complexes.
The hydrophobic effect is entropy-driven, not attraction-based: When nonpolar surfaces are buried upon binding, ordered water molecules are released to bulk solvent, gaining entropy (TΔS). This contributes ~0.02-0.04 kcal/mol per Ų of buried nonpolar surface—often exceeding hydrogen bond contributions.